Safe Handling Of Cytotoxic Compounds

A limited number of companies have the capabilities of handling cytotoxic compounds safely and efficiently and even fewer offer expertise in R&D. BTL is unique in now being able to bring together its R&D expertise in the lyophilization of products, with a dedicated facility for cytotoxic products. The facility is constructed to a Class 7 standard and offers exemplary separation and safety features. This facility went live in March 2012 and has already attracted an impressive order book and interest from all parts of the cytotoxic development community. This facility will match the cytotoxic marketplace with BTL’s existing product and process development skills of:

• Characterization
• Formulation development
• Lyophilization cycle development
• Development and product sale containment
• Small scale production
• Scale up advice and technology transfer